Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Enovis CORPCFX · Entity 4797 | Howden CEO | March 11, 2019 | March 13, 2019 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Enovis CORP
Report date March 11, 2019 · Filed March 13, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, par value $.001SEC Table I · non-derivative | Direct | 21,876 |
Reported balance
After 2019-03-11 transaction · row 1
1 source rowRow 1 · 2019-03-11 · Sale · Disposed 4,260 · Balance 21,876 F1: These shares were sold to meet tax obligations relating to the vesting and delivery of the first tranche of restricted stock units granted in March 2018. |
| Common Stock, par value $.001SEC Table I · non-derivative | IndirectBy spouse | 905 |
Reported balance
Holding disclosure · report date 2019-03-11 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 905 |
Filing footnotes · ownership attribution and instrument terms
F1: These shares were sold to meet tax obligations relating to the vesting and delivery of the first tranche of restricted stock units granted in March 2018.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 11, 2019 Filed Mar 13, 2019 20:38 UTC | Enovis CORP CFX · Entity 4797 | SaleCommon Stock, par value $.001 | 4,260 | $27.01 | $115,054.08 |
DisclosureSEC source: 0001209191-19-019172 · doc4.xml · nonDerivative · entry 1 Brander Ian · CIK 0001542337 · Howden CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,876 F1 · kind: These shares were sold to meet tax obligations relating to the vesting and delivery of the first tranche of restricted stock units granted in March 2018. F1 · shares: These shares were sold to meet tax obligations relating to the vesting and delivery of the first tranche of restricted stock units granted in March 2018. Read SEC document |
| March 01, 2019 Filed Mar 6, 2019 01:21 UTC | Enovis CORP CFX · Entity 4797 | GrantEmployee Stock Option (right to buy) · Derivative | 45,977 | $0.00 Strike: $26.52 | $0.00 |
DisclosureSEC source: 0001209191-19-017165 · doc4.xml · derivative · entry 1 Brander Ian · CIK 0001542337 · Howden CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,977 Underlying: Common Stock, par value $.001 · 45,977 shares Expires 2026-02-27 F1 · derivative.exercise_date: The option vests in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| November 19, 2018 Filed Nov 21, 2018 21:01 UTC | Enovis CORP CFX · Entity 4797 | SaleCommon Stock, par value $.001 | 3,232 | $26.18 | $84,610.53 |
DisclosureSEC source: 0001209191-18-059703 · doc4.xml · nonDerivative · entry 1 Brander Ian · CIK 0001542337 · Howden CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,136 F1 · kind: These shares were sold to meet tax obligations relating to the vesting and delivery of the first tranche of performance-based restricted stock units granted in November 2015. F1 · shares: These shares were sold to meet tax obligations relating to the vesting and delivery of the first tranche of performance-based restricted stock units granted in November 2015. Read SEC document |
| August 03, 2018 Filed Aug 7, 2018 20:23 UTC | Enovis CORP CFX · Entity 4797 | GrantCommon Stock, par value $.001 | 14,373 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-045676 · doc4.xml · nonDerivative · entry 1 Brander Ian · CIK 0001542337 · Howden CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,368 F1 · kind: Reflects the certification of the performance criteria for previously awarded performance-based restricted stock units ("PRSUs"), which PRSUs vest over time. For more details on the PRSUs, please refer to the "Outstanding Equity Awards" table on page 39 of the Company's Proxy Statement as filed with the SEC on April 5, 2018. F1 · shares: Reflects the certification of the performance criteria for previously awarded performance-based restricted stock units ("PRSUs"), which PRSUs vest over time. For more details on the PRSUs, please refer to the "Outstanding Equity Awards" table on page 39 of the Company's Proxy Statement as filed with the SEC on April 5, 2018. Read SEC document |
| March 08, 2018 Filed Mar 12, 2018 20:56 UTC | Enovis CORP CFX · Entity 4797 | GrantEmployee Stock Option (right to buy) · Derivative | 33,849 | $0.00 Strike: $33.41 | $0.00 |
DisclosureSEC source: 0001209191-18-018887 · doc4.xml · derivative · entry 3 Brander Ian · CIK 0001542337 · Howden CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,849 Underlying: Common Stock, par value $.001 · 33,849 shares Expires 2025-03-07 F2 · derivative.exercise_date: The option vests in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| March 08, 2018 Filed Mar 12, 2018 20:56 UTC | Enovis CORP CFX · Entity 4797 | GrantCommon Stock, par value $.001 | 9,144 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-018887 · doc4.xml · nonDerivative · entry 1 Brander Ian · CIK 0001542337 · Howden CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,995 F1 · shares: Represents restricted stock units. Read SEC document |
| February 20, 2018 Filed Feb 22, 2018 21:23 UTC | Enovis CORP CFX · Entity 4797 | SaleCommon stock, par value $.001 | 1,240 | $33.46 | $41,492.88 |
DisclosureSEC source: 0001209191-18-012413 · doc4.xml · nonDerivative · entry 1 Brander Ian · CIK 0001542337 · Howden CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,851 F1 · kind: These shares were sold to meet tax obligations relating to the vesting and delivery of performance-based restricted stock units. Read SEC document |
| February 24, 2017 Filed Feb 28, 2017 21:11 UTC | Enovis CORP CFX · Entity 4797 | SaleCommon stock, par value $.001 | 596 | $38.17 | $22,747.53 |
DisclosureSEC source: 0001209191-17-015259 · doc4.xml · nonDerivative · entry 1 Brander Ian · CIK 0001542337 · Howden CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,091 F1 · kind: These shares were sold to meet tax obligations relating to the delivery of performance-based restricted stock units. Read SEC document |
| February 21, 2017 Filed Feb 23, 2017 21:21 UTC | Enovis CORP CFX · Entity 4797 | SaleCommon stock, par value $.001 | 1,243 | $39.74 | $49,394.33 |
DisclosureSEC source: 0001209191-17-013768 · doc4.xml · nonDerivative · entry 1 Brander Ian · CIK 0001542337 · Howden CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,687 F1 · kind: These shares were sold to meet tax obligations relating to the delivery of performance-based restricted stock units. Read SEC document |
| February 13, 2017 Filed Feb 15, 2017 21:18 UTC | Enovis CORP CFX · Entity 4797 | GrantEmployee Stock Option (right to buy) · Derivative | 42,123 | $0.00 Strike: $40.47 | $0.00 |
DisclosureSEC source: 0001209191-17-011053 · doc4.xml · derivative · entry 1 Brander Ian · CIK 0001542337 · Howden CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,123 Underlying: Common Stock, par value $.001 · 42,123 shares Expires 2024-02-12 F1 · derivative.exercise_date: The option vests in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.